Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹468 Cr.
Stock P/E
1134.6
P/B
0.8
Current Price
₹2.1
Book Value
₹ 2.6
Face Value
1
52W High
₹2.3
52W Low
₹ 0.5
Dividend Yield
0%

Evexia Lifecare Overview

Business

Evexia Lifecare Ltd. is primarily engaged in the business of trading. The company acts as an intermediary, sourcing a diverse range of products from suppliers and selling them to customers across various industries. Its product portfolio includes, but is not limited to, cotton, agricultural products, ferrous & non-ferrous metals, chemicals, and industrial products. The core business model involves leveraging market knowledge and logistical efficiency to buy products at competitive prices and sell them at a margin, generating revenue from the price differential and trading volumes.

Revenue Mix

The company's revenue is derived from its broad trading activities across multiple product categories. Detailed segment-wise revenue breakdown (e.g., specific percentages from cotton, metals, chemicals) is typically not disclosed in public filings for companies of this nature. The revenue mix is dynamic and dependent on market demand and supply for the various commodities and industrial products it trades.

Industry

Evexia Lifecare operates in the highly fragmented and competitive trading sector in India. This industry is characterized by numerous players, ranging from small regional traders to large diversified conglomerates. Barriers to entry for basic trading operations are relatively low, but success requires strong capital, extensive networks, and efficient logistics. Given its current scale, Evexia Lifecare Ltd. positions itself as a diversified trader, competing with many smaller to medium-sized players, rather than being a dominant force in any specific commodity trading segment.

MOAT

Evexia Lifecare Ltd., as a general trading company of its size, does not appear to possess strong, durable competitive advantages typically associated with a "moat" (e.g., strong brand, proprietary technology, network effects, high switching costs). Any advantages it may have are likely operational:

Relationships: Established network of suppliers and buyers.

Sourcing & Logistics: Ability to source products cost-effectively and manage efficient supply chains.

Market Knowledge: Specific understanding of supply-demand dynamics and pricing in its traded categories.

These advantages, however, are often replicable by competitors and do not provide a sustained, hard-to-overcome moat.

Growth Drivers

Economic Growth: India's overall economic expansion and industrial growth will drive demand for various commodities and industrial products traded by the company.

Product Portfolio Expansion: Identifying and entering new, profitable product categories or niche markets.

Supply Chain Optimization: Enhancing sourcing capabilities and logistical efficiencies to reduce costs and improve margins.

Strategic Partnerships: Forging alliances with larger manufacturers, distributors, or international trading houses to increase volumes and reach.

Increased Trade Volumes: General increase in the demand and supply of commodities in its existing portfolio.

Risks

Commodity Price Volatility: Fluctuations in the prices of traded goods (cotton, metals, chemicals) can significantly impact inventory values and profit margins.

Intense Competition: The fragmented nature of the trading sector can lead to price wars and pressure on margins.

Supply Chain Disruptions: Issues in sourcing, transportation, or logistics (e.g., natural disasters, geopolitical events) can affect operations and profitability.

Credit Risk: Risk of default from counterparties, especially when extending credit to buyers.

Regulatory Changes: Changes in trade policies, tariffs, or import/export regulations can impact business operations and costs.

Working Capital Management: Efficient management of inventory and accounts receivable/payable is crucial for liquidity and profitability, and failure to do so poses a risk.

Management & Ownership

Evexia Lifecare Ltd. is a promoter-driven company. Promoters typically hold a significant stake, aligning their interests with the company's performance. For instance, Mr. Sandeep G Singh and Mr. Rahul Kumar Singh are associated with the management and promoter group. The quality of management is largely tied to the experience and reputation of these key individuals in the trading and commodity markets. The remaining ownership is held by public shareholders.

Outlook

Evexia Lifecare operates in a fundamental segment of the economy, facilitating trade in essential commodities and industrial goods. The company could benefit from sustained economic growth in India, which fuels demand across sectors. Its diversified product portfolio allows it to capture opportunities in various markets. However, the trading sector is inherently low-margin, highly competitive, and exposed to significant commodity price volatility and supply chain risks. Without a clear, sustainable competitive moat, its ability to achieve consistent, superior profitability and growth might be challenged. Its small scale also limits bargaining power and access to capital compared to larger trading houses. Future performance will largely depend on management's ability to efficiently manage inventory, mitigate price risks, optimize logistics, and cultivate strong supplier and customer relationships in a dynamic market environment.

Evexia Lifecare Share Price

Live · BSE · Inception: 1990
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Evexia Lifecare Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Jun 2026
Net Sales 7 25 21 27 22 24 22 26 25 31
Other Income 0 1 0 0 0 0 0 0 0 0
Total Income 7 26 21 27 22 24 22 26 26 31
Total Expenditure 7 22 21 26 22 22 21 26 25 30
Operating Profit -0 4 0 1 0 1 1 1 1 1
Interest -0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -0 3 0 1 0 0 1 1 0 1
Provision for Tax -0 1 0 0 0 0 0 0 0 0
Profit After Tax -0 3 0 1 0 0 1 0 0 0
Adjustments 0 -0 0 0 0 0 0 -0 0 -0
Profit After Adjustments -0 3 0 1 0 0 1 0 0 0
Adjusted Earnings Per Share -0 0 0 0 0 0 0 0 0 0

Evexia Lifecare Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 1 34 178 74 105 100 107 76 70 56 87 104
Other Income 0 1 0 1 3 12 74 0 2 1 0 0
Total Income 1 34 178 75 109 112 181 76 71 57 87 105
Total Expenditure 1 34 176 74 106 107 179 73 69 54 85 102
Operating Profit 0 0 1 1 3 5 2 2 2 3 2 4
Interest 0 0 0 0 0 0 0 0 1 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses -0 -0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 1 1 2 5 2 2 2 2 1 3
Provision for Tax 0 0 0 0 1 1 1 1 1 1 1 0
Profit After Tax 0 0 1 0 2 3 1 1 1 1 0 1
Adjustments 0 0 0 0 -0 0 0 0 0 -0 0 0
Profit After Adjustments 0 0 1 0 2 3 1 1 1 1 0 1
Adjusted Earnings Per Share 0 0 0 0 0 0.1 0 0 0 0 0 0

Evexia Lifecare Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 66 65 66 73 75 78 80 80 90 130 460
Minority's Interest 0 0 0 0 0 0 0 0 -0 -0 -0
Borrowings 0 9 4 6 4 1 0 0 696 682 375
Other Non-Current Liabilities 3 0 111 114 97 83 10 15 15 0 0
Total Current Liabilities 5 37 38 15 48 61 52 32 47 64 60
Total Liabilities 74 112 219 208 224 224 142 127 848 875 894
Fixed Assets 2 2 2 9 9 9 9 9 11 11 11
Other Non-Current Assets 69 48 56 127 128 86 24 48 749 767 784
Total Current Assets 3 61 161 72 88 129 109 70 87 97 100
Total Assets 74 112 219 208 224 224 142 127 848 875 894

Evexia Lifecare Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents -0 1 2 1 1 1 0 1 2 0 1
Cash Flow from Operating Activities 4 11 -116 -12 -0 -3 2 -6 -3 17 -4
Cash Flow from Investing Activities 0 2 1 -6 0 1 -2 8 -697 -17 -16
Cash Flow from Financing Activities -4 -12 113 18 0 2 1 -1 699 1 20
Net Cash Inflow / Outflow 1 1 -2 -0 0 -0 0 1 -1 0 -0
Closing Cash & Cash Equivalent 1 2 -1 1 1 0 1 2 0 1 1

Evexia Lifecare Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0 0 0.01 0.01 0.03 0.06 0.02 0.01 0.01 0.02 0
CEPS(Rs) 0 0 0.02 0.01 0.03 0.06 0.02 0.02 0.02 0.03 0
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 1.05 1.06 1.06 1.06 1.09 1.15 1.17 1.17 1.25 1.72 2.3
Core EBITDA Margin(%) -8.29 -0.31 0.72 -0.48 -0.85 -6.29 -67.74 3.2 0.84 3.25 1.94
EBIT Margin(%) 26.7 0.96 0.76 1 2.15 5.09 1.81 3.01 2.98 4.08 1.55
Pre Tax Margin(%) 24.04 0.8 0.75 0.98 2.13 4.88 1.8 2.88 2.2 3.43 1.06
PAT Margin (%) 16.4 0.48 0.5 0.65 1.48 3.46 1.2 1.14 0.96 2.45 0.48
Cash Profit Margin (%) 47.05 0.72 0.55 0.89 1.79 3.77 1.43 1.42 1.52 3.19 1.02
ROA(%) 0.16 0.18 0.54 0.23 0.72 1.55 0.7 0.64 0.14 0.16 0.05
ROE(%) 0.3 0.25 1.37 0.73 2.35 5.01 1.79 1.19 0.86 1.35 0.15
ROCE(%) 0.27 0.44 1.86 1.05 3.16 6.81 2.46 2.89 0.48 0.29 0.16
Receivable days 1053.69 127.5 165.88 429.9 159.71 228.23 195.07 147.04 122 397.25 382.44
Inventory Days 157.3 3.41 1.26 3.41 2.49 2.65 6.68 11.23 8.81 10.1 6.71
Payable days 179.26 193.02 73.2 124.62 102.29 169.8 251.59 145.42 160.19 340.48 265.28
PER(x) 630.43 324.44 183.87 203.32 163.05 148.26 708.94 205.71 119.85 127.6 1186.36
Price/Book(x) 1.03 0.82 2.51 1.49 3.78 7.22 12.59 2.45 1.31 1.42 1.14
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 114.28 1.84 0.94 1.4 2.44 5.2 8.58 2.42 11.68 15.18 9.98
EV/Core EBITDA(x) 187.45 153.5 117.01 112.92 99.66 96.32 420.67 73.52 329.94 314.94 475.6
Net Sales Growth(%) -16.61 5378.97 422.71 -58.26 42.27 -4.95 6.42 -29.18 -7.89 -19.1 53.88
EBIT Growth(%) 108.77 86.76 317.22 -45.28 205.71 125.22 -62.11 17.72 -9.07 10.96 -41.44
PAT Growth(%) 52.48 54.06 444.63 -46.11 224.11 121.73 -63.03 -32.79 -22.66 106.87 -70.09
EPS Growth(%) -78.82 54.2 443.86 -46.11 222.97 122.63 -63.07 -32.37 -2.86 41.18 -88.54
Debt/Equity(x) 0.07 0.16 0.05 0.09 0.06 0.1 0.09 0.08 8.5 5.59 0.87
Current Ratio(x) 0.67 1.67 4.2 4.92 1.82 2.11 2.08 2.18 1.86 1.51 1.66
Quick Ratio(x) 0.63 1.66 4.18 4.88 1.8 2.1 2.02 2.14 1.82 1.5 1.63
Interest Cover(x) 10.05 5.95 64.08 40.06 130.22 24.43 162.5 22.6 3.83 6.29 3.15
Total Debt/Mcap(x) 0.07 0.2 0.02 0.06 0.02 0.01 0.01 0.03 6.51 3.93 0.76

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +55% +5% -3% +56%
Operating Profit CAGR -33% 0% -17% —
PAT CAGR -100% -100% -100% —
Share Price CAGR +3% +8% -21% +2%
ROE Average 0% +1% +1% +1%
ROCE Average 0% 0% +1% +2%

Evexia Lifecare Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 3.36 %
FII 0 %
DII (MF + Insurance) 0.1 %
Public (retail) 96.54 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 9.266.295.873.493.493.493.363.493.363.36
FII 01.031.490.160.1600.470.470.120
DII 0.260.180.170.10.10.10.10.10.10.1
Public 90.4892.592.4796.2596.2596.4196.0795.9496.4196.54
Others 0000000000
Total 100100100100100100100100100100

Evexia Lifecare Peer Comparison

Evexia Lifecare Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Evexia Lifecare Pros & Cons

Pros

  • Stock is trading at 0.8 times its book value
  • Debtor days have improved from 340.48 to 265.28days.
  • Company has reduced debt.

Cons

  • Promoter holding is low: 3.36%.
  • Company has a low return on equity of 1% over the last 3 years.
  • The company has delivered a poor profit growth of -100% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp